01 December 2005
Patents 101
George B. Stefano, J. Patrick Finn IIIMed Sci Monit 2005; 11(12): ED9-10 :: ID: 438814
Abstract
The following discussion provides some general points regarding patent rights and the requirements for obtaining a patent. A patent provides its owner with certain rights to the invention that is recited in the “claims” of the patent. In the United States, those rights include the right to exclude others from making, using, importing, offering for sale, and selling the claimed invention. A patent does not provide its owner with the right to do these activities but rather provides its owner with the right to exclude others from doing them. Owning a patent on an invention does not ensure that you do not infringe some other patent. For example, it is possible for a fi rst inventor to patent compound X, and a second inventor to later patent the use of compound X to treat a particular disease. In this case, the second inventor’s use of compound X would be infringing the fi rst inventor’s patent to compound X. In the United States, the United States Patent and Trademark Offi ce issues patents, which can be in force for up to 20 years from the patent’s earliest claimed priority date. This means that a patent that claims priority to an earlier fi led patent application will expire 20 years from the fi ling date of that earlier patent application. You may also fi le a “provisional” patent application and follow it with a “real” utility application within a year, without starting the 20-year clock until the later fi ling. Other countries calculate patent term in a similar manner. In some cases, a patent may expire before the 20 years. For example, a patent owner may have been required to disclaim a terminal portion of a patent’s term to overcome an examiner’s rejection raised during examination. A review of the issued patent and its fi le history typically reveals
the presence of any fi led terminal disclaimers of patent term. In addition, failure to pay post-issuance
maintenance or annuity fees can lead to a patent expiring prior to the date 20 years from the
earliest claimed priority date.
Keywords: United States, Patents as Topic - legislation & jurisprudence
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952